Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

Q-linea Registered: loss per share significantly reduced, revenue rises 508.77%

Q-linea Registered published results for the quarter ended 30.09.2025. Loss per share fell to 6.55 SEK from -50,940 SEK in the same quarter a year earlier. Revenue increased to 3.5 million SEK, up 508.77% from 0.6 million SEK in the prior year. » Altro su finanzen.net
Q-linea reports 370% rise in recurring revenue and plans cost cuts

Q-linea recorded a 370% year‑on‑year increase in recurring revenue in Q3 2025. The company reduced headcount from 150 to 83 employees and aims to lower monthly operating costs to SEK 11.3–11.8 million by 2026. Q-linea holds SEK 42.6 million in cash, plans a rights issue of SEK 322 million (85.6% secured) and targets installation of 30 ASTar systems by year‑end; the V2 menu is planned for FDA submission. The share price traded slightly weaker after the earnings call (-0.02%). » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, Q-LINEA AB ha registrato ricavi pari a 135,36K € e un utile netto di -2,7 Mln €

(EUR)	giu 2026	YoY
Ricavi	135,36K	39,26%
Utile lordo	-3,11 Mln	2012,46%
Utile netto	-2,7 Mln	37,48%
EBITDA	-2,78 Mln	28,82%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	11,04 Mln €
Numero di azioni	6,66 Mln
Massimo/minimo a 52 settimane	4,72 € - 1,31 €
Dividendi	No
Beta	0,59
Rapporto P/E	-1,40
Rapporto PEG	0,02
Rapporto P/B	1,27
Rapporto P/S	12,46

Profilo aziendale

Q-linea AB (publ) beschäftigt sich mit der Entwicklung von Instrumenten und Verbrauchsmaterialien für die Infektionsdiagnostik in Schweden. Das Unternehmen bietet innovative Systeme für die In-vitro-Diagnostik von Infektionskrankheiten an. Der führende Produktkandidat des Unternehmens ist ASTar, ein System zum Testen der Antibiotikaempfindlichkeit bei positiven Blutkulturen. Das Unternehmen entwickelt und liefert Lösungen für Gesundheitsdienstleister. Q-linea AB (publ) wurde im Jahr 2008 gegründet und hat seinen Hauptsitz in Uppsala, Schweden.